Norwogonin is used in pharmaceutical research due to its anti-inflammatory and antioxidant properties. It shows potential in managing neurodegenerative diseases by inhibiting oxidative stress and reducing neuronal damage. Studies suggest it may help in cancer prevention by inducing apoptosis in abnormal cells and suppressing tumor growth. It also exhibits antiviral activity, particularly against certain RNA viruses, making it a candidate for antiviral drug development. In skincare, norwogonin is explored for its ability to protect skin from UV damage and reduce signs of aging. Its enzyme-inhibiting effects are being investigated for use in diabetes management, where it may help regulate blood sugar levels.